Hyderabad, Dec 14 (ANI/Business Wire India): GVK Biosciences (GVK BIO), Asia's leading integrated research services organization announced the appointment of Dr. Cecil B. Pickett as Scientific Advisor to the Board of Directors.
Cecil B. Pickett, Ph.D. has served as President of Research and Development, and member of the Biogen Idec Board of Directors for three years (March 2006-October 2009).
Prior to joining Biogen Idec, Dr. Pickett held several senior R and D positions at Schering-Plough Corporation. As the Senior Vice President and President, Schering-Plough Research Institute, Dr. Pickett helped bring several large and small molecule candidates into the Schering-Plough clinical development pipeline. Prior to joining Schering-Plough, he held several senior R and D positions at Merck and Company.
D.S.Brar, Chairman, GVK Biosciences, commented "Dr. Pickett is an acknowledged scientific leader and brings vast knowledge and experience regarding the interests and demands of pharmaceutical and biotech customers to our Scientific Advisory Board. His experience in drug metabolism, molecular pharmacology and expertise in leading drug discovery initiatives, will be invaluable to GVK BIO as we build our organization to provide a wide range of scientific solutions globally".
Dr. Pickett commented "GVK Biosciences is a leader in contract research services and has built a strong and capable management and scientific team. I am excited to participate in GVK Biosciences growth strategies and look forward to contributing to the scientific advancement and development of GVK BIO".
Dr. Pickett received his B.S. in Biology from California State University, Hayward, Calif., and his Ph.D. in Cell Biology from the University of California, Los Angeles (UCLA). (ANI)
|
|
Comments:
